Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
Prostate Cancer Diagnosis
Details
This new edition presents new perspectives and technologies. It details substantial developments in techniques and complications. It also presents new data on the controversial issue of PSA screening and thresholds as indication to perform biopsy.
Chapters authored by a complete spectrum of specialists
Provides many new perspectives and technologies
Based on the highly successful first edition
Presents new data on controversial issues of screening
Chapters authored by a complete spectrum of specialists Provides many new perspectives and technologies Based on the highly successful first edition Presents new data on controversial issues of screening Includes supplementary material: sn.pub/extras
Inhalt
Ch.1: Defining the Problem.- Ch.2: Prostate Cancer Screening: Navigating the Controversy.- Ch.3: Is the PSA Era Over?.- Ch.4: PSA Dynamics.- Ch.5: Percent Free PSA.- Ch.6: PCA3 and other Urinary Markers.- Ch.7: Blood-Based Tumor Markers for Prostate Cancer.- Ch.8: Prediction Models in Prostate Cancer Diagnosis and Preparation for Biopsy.- Ch.9: Is There a Role for Medications to Reduce the Need for Prostate Biopsy?.- Ch.10: Indications For Initial Biopsy: Is The PSA Threshold Over?.- Ch.11: Preparation for Prostate Biopsy.- Ch.12: Pain Prevention.- Ch.13: Prostate Biopsy.- Ch.14: Prostate Biopsy Techniques.- Ch.15: Transperineal Biopsy.- Ch.16: Pathological Implications of Prostate Biopsy.- Ch.17: Complications of Transrectal Ultrasound Guided Prostate Biopsy.- Ch.18: After the Biopsy: Management of High Grade Prostatic Intraepithelial Neoplasia (HGPIN).- Ch.19: Atypical Small Acinar Proliferation.- Ch.20: Repeat Prostate Biopsy Strategies Indications and Techniques.- Ch.21: Transperineal Mapping Biopsy of the Prostate for Assessment of the Minimal Risk Patient.- Ch.22: Management of the Patient Following a Negative Biopsy: Saturation Biopsy.- Ch.23: Role of imaging as an adjunct or replacement for biopsy: American Experience.- Ch.24: Role Of Imaging As An Adjunct Or Replacement For Biopsy: European Experience.- Ch.25: Prostate Cancer Detection: Lessons Learnt in the Cleveland Clinic Experience with Focus on the Negative Biopsy.- Ch.26: Future Directions in Prostate Cancer Diagnosis.
Weitere Informationen
- Allgemeine Informationen
- Sprache Englisch
- Editor J. Stephen Jones
- Titel Prostate Cancer Diagnosis
- Veröffentlichung 14.11.2012
- ISBN 1627031871
- Format Fester Einband
- EAN 9781627031875
- Jahr 2012
- Größe H260mm x B183mm x T25mm
- Untertitel PSA, Biopsy and Beyond
- Gewicht 947g
- Auflage 2013
- Genre Medizin
- Lesemotiv Verstehen
- Anzahl Seiten 400
- Herausgeber Humana Press
- GTIN 09781627031875